Predicting the future in idiopathic rapid-eye movement sleep behaviour disorder

Comment

Bradley F Boeve. Lancet Neurol. 2010 Nov.

. 2010 Nov;9(11):1040-2.

doi: 10.1016/S1474-4422(10)70221-0. Epub 2010 Sep 24.

No abstract available

Comment on

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavía J, Gallego J, Seppi K, Högl B, Tolosa E, Poewe W, Santamaria J; Sleep Innsbruck Barcelona (SINBAR) group. Iranzo A, et al. Lancet Neurol. 2010 Nov;9(11):1070-7. doi: 10.1016/S1474-4422(10)70216-7. Epub 2010 Sep 16. Lancet Neurol. 2010. PMID: 20846908